STI571 (Gleevec) as a paradigm for cancer therapy (Q34583847)

3 August 2017

1 reference

title

STI571 (Gleevec) as a paradigm for cancer therapy (English)

1 reference

3 August 2017

1 reference

Brian J Druker

1

0 references

publication date

1 January 2002

1 reference

Trends in Molecular Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

4 Suppl

1 reference

3 August 2017

page(s)

S14-8

1 reference

Chronic myelogenous leukemia: biology and therapy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Chronic myeloid leukemia: current treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Acute leukaemia in bcr/abl transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Roots of clinical resistance to STI-571 cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902305-5

7 January 2021

10.1016/S1471-4914(02)02305-5

Identifiers

DOI

1 reference

3 August 2017

1 reference